NEW YORK – The US National Academy of Medicine (NAM), the US National Academy of Sciences (NAS), and the Royal Society of the UK this week convened the first meeting of the International Commission on the Clinical Use of Human Germline Genome Editing in Washington, DC, to obtain information on the state of genome editing technology and develop a framework for the scientific and regulatory communities on the appropriate use of germline genome editing.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.